Blood cultures from arterial lines: does it change contamination, bacteremia detection, and how much blood is drawn?

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study examines blood cultures drawn from arterial catheters in ICU patients to see if this method influences contamination and bacteremia detection, and to quantify the blood volume per bottle. It analyzes routine care data from January 2024 through January 2027 at Meir Medical Center. The goal is to understand whether arterial-line draws impact diagnostic quality and to identify opportunities to improve sample volumes. Patients include adults admitted to the ICU who had bloodstream cultures drawn as part of standard care. Exclusion applies to missing data or those not meeting criteria.

Why it matters

Who can join: the full rules

Inclusion Criteria:All patients aged 18-99 years who had blood cultures taken as part of their routine care in the intensive care unit for any reason, from January 2024 to January 2027.

\-

Exclusion Criteria:Missing data or patients who did not fullfil the above criteria.

\-

Where it's running

• Meir Medical Center
  Kfar Saba, Israel Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• UllCORE BSI Test for Bloodstream Infections

  This study tests whether the UllCORE BSI Test can correctly detect bloodstream infection pathogens and resistance markers from whole blood in people with suspected infection or sepsis.

  Recruiting Deepull Diagnostics S.L. · Orange, California and 19 other locations · NCT07859852

• Beta-lactam plus levofloxacin for streptococcal bacteremia

  This trial tests whether adding levofloxacin to standard beta-lactam therapy helps adults with streptococcal bacteremia see better outcomes.

  Recruiting at 2 sites Phase 4 Mahidol University · Bangkok and 3 other locations · NCT07240077

• New care guideline for infants 60 days and younger with fever in Sweden

  This project will test a new guideline to see if infants 60 days or younger with fever can safely avoid many invasive tests, hospital stays, and broad antibiotics compared with usual care.

  Recruiting at 9 sites Region Skane · Gothenburg and 10 other locations · NCT07134751

• GRADY: a computer tool to detect early sepsis and gram-negative bloodstream infection in ICU patients

  The GRADY tool will be tested to see if routine vital signs and lab results can detect early sepsis and gram-negative bloodstream infection in adult ICU patients.

  Recruiting Sisli Hamidiye Etfal Training and Research Hospital · Seyrantepe, Istanbul · NCT07126106

• Linezolid added to standard care for Staphylococcus aureus bloodstream infection

  This trial will test whether giving linezolid in addition to usual antibiotics helps adults hospitalized with Staphylococcus aureus bloodstream infections.

  Recruiting at 12 sites University Hospital, Basel, Switzerland · Aarau, Canton of Aargau and 11 other locations · NCT06958835

• Examining biofilm in arterial catheters in ICU patients

  This study looks at the germs that build up on arterial catheters in ICU patients to see how they might cause infections and find better ways to prevent them.

  Recruiting at 2 sites Centre Hospitalier William Morey - Chalon sur Saône · Dijon, Bourgogne-Franche-Comté and 1 other locations · NCT06838598

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.